SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-029714
Filing Date
2022-08-18
Accepted
2022-08-18 07:15:30
Documents
15
Period of Report
2022-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sdgr-8k_20220816.htm   iXBRL 8-K 71158
2 EX-10.1 sdgr-ex101_7.htm EX-10.1 296264
3 EX-10.2 sdgr-ex102_6.htm EX-10.2 138899
4 GRAPHIC gcvfme3g2d0g000001.jpg GRAPHIC 38302
  Complete submission text file 0001564590-22-029714.txt   761165

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sdgr-20220816.xsd EX-101.SCH 5601
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20220816_lab.xml EX-101.LAB 19320
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20220816_pre.xml EX-101.PRE 11495
9 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-8k_20220816_htm.xml XML 3540
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 221176315
SIC: 2834 Pharmaceutical Preparations